Target Aware De Novo Generation
- 3D-Generative-SBDD: Focuses on structure-based drug design (SBDD) using a 3D generative model to sample molecules for specific protein pockets.
- AlphaDrug: protein target specific de novo molecular generation (generative chemistry) (standalone).
- BindDM: BindDM extracts subcomplex from protein-ligand complex, and utilizes it to enhance the binding-adaptive 3D molecule generation in complex
- cMolGPT: cMolGPT, a Conditional Generative Pre-trained Transformer, aims for de novo molecular design by enforcing target specificity during the generation process, emphasizing the incorporation of target embeddings.
- DESERT: Zero-shot 3D drug design by sketching and generating, as presented at NeurIPS 2022.
- DRAGONFLY:
- DrugGEN: Target Specific De Novo Design of Drug Candidate Molecules with Graph Transformer-based Generative Adversarial Networks
- DrugHIVE: Structure-Based Drug Design with a Deep Hierarchical Generative Model
- HySonLab: Multimodal protein representation learning and target-aware variational auto-encoders for protein-binding ligand generation
- Ligand_Generation: This project focuses on target-aware variational autoencoders for ligand generation, employing multimodal protein representation learning for structure-based drug design.
- PCMol: A multi-target model for de novo molecule generation, using AlphaFold protein embeddings for thousands of protein targets.
- PETrans: PETrans: De Novo Drug Design with Protein-Specific Encoding Based on Transfer Learning
- Pocket2Mol: Uses equivariant graph neural networks for efficient molecular sampling based on 3D protein pockets.
- PocketFlow: data-and-knowledge driven structure-based molecular generative model
- RELATION: A software for DL-based de novo drug design, focusing on generating molecules based on target protein interactions.
- ResGen: pocket-aware 3D molecular generation model based on parallel multiscale modelling (standalone).
- SCRdkit: assesses the 3D similarity between generated molecules and a reference molecule
- SINGA: SINGA is a Molecular Sampling model with Protein-Ligand Interactions aware Generative Adversarial Network, focusing on generating molecules considering their interactions with proteins.
Active-learning
- ChemSpaceAL: an Efficient Active Learning Methodology Applied to Protein-Specific Molecular Generation (generative chemistry) (standalone, 2024).
Benchmarks
- CBGBench:
- From Theory to Therapy: Reframing SBDD Model Evaluation via Practical Metrics: From Theory to Therapy: Reframing SBDD Model Evaluation via Practical Metrics
Diffusion
- DiffDec: A model that uses an end-to-end equivariant diffusion process for optimizing molecular structures through scaffold decoration conditioned on 3D protein pockets.
- DiffSBDD: Structure-based Drug Design with Equivariant Diffusion Models (standalone, 2024).
- MolSnapper: Conditioning Diffusion for Structure Based Drug Design
- TargetDiff: 3D Equivariant Diffusion for Target-Aware Molecule Generation and Affinity Prediction (standalone, 2024).
Docking-based
- DockStream: DockStream: a docking wrapper to enhance de novo molecular design
- FREED: Utilizes explorative experience replay in a generative reinforcement learning setup for drug design.
- KGDiff: A model for explainable target-aware molecule generation with knowledge guidance.
- Lib-INVENT: Reaction-based Generative Scaffold Decoration for in Silico Library Design
- liGAN: A project for structure-based drug discovery using deep generative models of atomic density grids.
- LS-MolGen: A ligand-and-structure dual-driven deep reinforcement learning method for target-specific molecular generation, integrating docking scores and bioactivity data for molecule optimization.
- MORLD: Autonomous molecule generation using reinforcement learning and docking to develop potential novel inhibitors
- OptiMol: OptiMol : Optimization of binding affinities in chemical space for drug discovery
- PMDM: dual diffusion model enables 3D binding bioactive molecule generation and lead optimization given target pockets
- PocketOptimizer 2.0: Design of small molecule‐binding pockets in proteins (standalone)
- RGA: A reinforcement learning-based genetic algorithm for structure-based drug design, introduced at NeurIPS 2022.
- SampleDock: Navigating Chemical Space By Interfacing Generative Artificial Intelligence and Molecular Docking
- SBMolGen: integrates a recurrent neural network, a Monte Carlo tree search, and docking simulations
- SECSE: Systemic evolutionary chemical space exploration for drug discovery
Dual-target
- Alx-Fuse: Structure-Aware Dual-Target Drug Design through Collaborative Learning of Pharmacophore Combination and Molecular Simulation
Fragment-based
Interaction fingerprint constrained
Language Model
- Lingo3DMol: A pocket-based 3D molecule generation method that combines language model capabilities with 3D coordinate generation and geometric deep learning.
PROTACs
- PROTACable: Integrative Computational Pipeline of 3-D Modeling and Deep Learning To Automate the De Novo Design of PROTACs (standalone, published 2024).
Pharmacophore
Physics-based generation
Protein-ligand interactions
- DeepICL: 3D molecular generative framework for interaction-guided drug design
- DrugGPS: Focuses on learning subpocket prototypes for generalizable structure-based drug design, introduced at ICML 2023.
- FLAG: A Fragment-based Ligand Generation framework to generate 3D molecules with valid and realistic substructures fragment-by-fragment.
- GraphBP: Implements a method for generating 3D molecules targeting protein binding, presented at ICML 2022.
RAG
Reviews
- Docking-based generative approaches in the search for new drug candidates [2022]: Docking-based generative approaches in the search for new drug candidates
- Generative Deep Learning for Targeted Compound Design [2021]: Generative Deep Learning for Targeted Compound Design
- Integrating structure-based approaches in generative molecular design [2023]: Integrating structure-based approaches in generative molecular design
- Structure-based Drug Design Benchmark: Do 3D Methods Really Dominate?: benchmark to evaluate the performance of sixteen models across these different algorithmic foundations by assessing the pharmaceutical properties of the generated molecules and their docking affinities with specified target proteins